Pegylated interferon for 52 weeks
Option | Explanation |
Lamivudine for 30+ weeks | Lamivudine was an early treatment for hepatitis B but has a low resistance threshold and is not first-line. |
Tenofovir for > 40 weeks | Tenofovir is effective, with a high barrier to resistance. It is appropriate for treating hepatitis B in this case. |
Pegylated interferon for 52 weeks | Interferon therapy can be used but is less commonly recommended due to side effects and lower efficacy in HBeAg positive cases specifically with high viral load. |
Combined pegylated interferon with lamivudine | This combination is generally not preferred due to potential for resistance and increased side effects. |
The primary source of energy for Earth’s climate system is:
The most common site of metastasis for breast cancer is:
Which of the following cranial nerves is responsible for the motor innervation of the muscles of mastication?
Which of the following is a characteristic feature of Parkinson’s disease?
Which enzyme is deficient in Gaucher’s disease?